Using virtual reality to reduce anxiety in women with suspected endometriosis during gynecological consultations
ENDOREV: A Solution to Reduce Anxiety During Gynecological Consultations in Patients With Suspected Endometriosis?
This study is testing if using virtual reality can help reduce anxiety for women with suspected endometriosis during their gynecological appointments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | Poissy-Saint Germain Hospital Academic / other |
| Locations | 1 site (Poissy) |
| Trial ID | NCT06655584 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of virtual reality therapy, specifically the Bliss DTX system, in reducing anxiety for patients with suspected endometriosis during gynecological consultations. It is a single-center, randomized, controlled trial involving 46 patients who will be divided into two groups: one receiving virtual reality therapy and the other receiving standard care. The intervention lasts for 13 minutes and aims to assess both anxiety levels and compliance with endometriosis monitoring. Data will be collected through questionnaires before and after consultations, as well as follow-up calls at six months.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 to 45 who are referred for their first gynecological consultation due to suspected endometriosis.
Not a fit: Patients with a history of major pelvic surgery for endometriosis, those undergoing hysterectomy, or individuals with psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety levels in patients undergoing gynecological consultations, improving their overall experience and compliance with follow-up care.
How similar studies have performed: Other studies have shown promising results using virtual reality for anxiety reduction in medical settings, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patient between 18 and 45 years old * Patient referred for suspected endometriosis * Patient consulting for the first time in the hospital * Patient with first-line or second-line imaging documenting endometriosis (ultrasound or MRI) * Patient agreeing to participate in the study and having signed informed consent * Patient affiliated to a social security scheme * Patient able to read and write French Exclusion Criteria: * • Patient with a history of major pelvic surgery for endometriosis * Patient undergoing hysterectomy * Virgin patient * Pregnant woman * Patient with psychiatric pathology * Patient suffering from proven epilepsy * Patient under judicial protection * Patient under guardianship or curatorship * Patient with visual or hearing impairment * Patient with a progressive pathology responsible for chronic pain
Where this trial is running
Poissy
- Poissy-Saint Germain Hospital — Poissy, France (Recruiting)
Study contacts
- Study coordinator: Elise LUNELLI
- Email: elise.lunelli@ght-yvelinesnord.fr
- Phone: +33139274581
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.